SUPT16H expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.992000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.080200E-01
Normal-vs-Stage2
6.351200E-01
Normal-vs-Stage3
1.408240E-01
Normal-vs-Stage4
9.817400E-01
Stage1-vs-Stage2
5.054600E-01
Stage1-vs-Stage3
2.518400E-01
Stage1-vs-Stage4
3.281000E-01
Stage2-vs-Stage3
8.270400E-02
Stage2-vs-Stage4
5.623200E-01
Stage3-vs-Stage4
1.466400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.190200E-01
Normal-vs-AfricanAmerican
6.886200E-01
Normal-vs-Asian
2.652200E-01
Caucasian-vs-AfricanAmerican
9.481600E-01
Caucasian-vs-Asian
3.356600E-01
AfricanAmerican-vs-Asian
5.682400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.344800E-01
Normal-vs-Female
6.848600E-01
Male-vs-Female
5.109000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.430600E-01
Normal-vs-Age(41-60Yrs)
8.833400E-01
Normal-vs-Age(61-80Yrs)
4.866800E-01
Normal-vs-Age(81-100Yrs)
8.371200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.173200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.045400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.952200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.280070E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.790800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.005800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.545000E-01
Normal-vs-Daily Drinker
8.113600E-01
Normal-vs-Weekly Drinker
7.411400E-01
Normal-vs-Occasional Drinker
8.562400E-01
Normal-vs-Social Drinker
5.295600E-01
Non Drinker-vs-Daily Drinker
2.646600E-01
Non Drinker-vs-Weekly Drinker
5.284400E-01
Non Drinker-vs-Occasional Drinker
8.640100E-02
Non Drinker-vs-Social Drinker
2.003000E-01
Daily Drinker-vs-Weekly Drinker
8.049600E-01
Daily Drinker-vs-Occasional Drinker
7.478600E-01
Daily Drinker-vs-Social Drinker
8.590200E-01
Weekly Drinker-vs-Occasional Drinker
6.152800E-01
Weekly Drinker-vs-Social Drinker
8.877000E-01
Occasional Drinker-vs-Social Drinker
4.844000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.268400E-01
Normal-vs-Grade 2
9.634000E-01
Normal-vs-Grade 3
9.868800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.092800E-01
Grade 1-vs-Grade 3
8.458400E-02
Grade 1-vs-Grade 4
9.268400E-01
Grade 2-vs-Grade 3
1.885760E-01
Grade 2-vs-Grade 4
9.634000E-01
Grade 3-vs-Grade 4
9.868800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.288200E-01
Normal-vs-NonDiabetic
5.913200E-01
Diabetic-vs-NonDiabetic
5.462200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.339170E-01
Normal-vs-NoPancreatitis
6.341200E-01
Pancreatitis-vs-NoPancreatitis
1.842360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.717800E-01
Normal-vs-N1
6.721600E-01
N0-vs-N1
5.496000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.220600E-01
Normal-vs-TP53-NonMutant
5.691400E-01
TP53-Mutant-vs-TP53-NonMutant
2.522500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
